Literature DB >> 6105026

Pancreatic somatostatinoma presenting with hypoglycaemia.

J Wright, A Abolfathi, E Penman, V Marks.   

Abstract

A 33-year-old woman with a 2 month history of vague ill health was admitted to hospital in hypoglycaemic coma. Preoperative investigation suggested malignant insulinoma as the probable cause of illness, but immunohistological examination of the tumour showed it to consist mainly of somatostatin-containing cells but sparse insulin-secreting cells were also present. Plasma immunoreactive somatostatin levels were from fifty to 200 times the upper limit of normal and rose in response to arginine and fell during diazoxide infusion. The hypoglycaemia was unusually sensitive to the hyperglycaemic effects of diazoxide and chlorothiazide and, with 5-fluorouracil as the only specific anti-tumour agent, there has been clinical, biochemical and radiological evidence of tumour regression.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105026     DOI: 10.1111/j.1365-2265.1980.tb01382.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Neurofibromatosis, phaeochromocytoma, and somatostatinoma.

Authors:  A M Cantor; C C Rigby; P R Beck; D Mangion
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

2.  Somatostatinoma--the most recently described pancreatic islet cell tumor.

Authors:  C Reynolds; R Pratt; C Chan-Yan; W Boyko; W MacDonald; N Schmidt; R Rudland
Journal:  West J Med       Date:  1985-03

3.  Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.

Authors:  V Schusdziarra; D Grube; H Seifert; J Galle; H Etzrodt; W Beischer; O Haferkamp; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1983-07-15

4.  Characterization of three peptides derived from prosomatostatin [prosomatostatin-(1-63)-, -(65-76)- and -(79-92)-peptides] in a human pancreatic tumour.

Authors:  J M Conlon; B Eriksson; L Grimelius; K Oberg; L Thim
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

5.  Distinct mechanisms of hypoglycaemia in patients with somatostatin-secreting neuroendocrine tumours.

Authors:  Peter Wiesli; Vojtech Pavlicek; Michael Brändle; Thomas Pfammatter; Aurel Perren; Christoph Schmid
Journal:  Endocrinol Diabetes Metab       Date:  2019-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.